13
Views
28
CrossRef citations to date
0
Altmetric
Original Article

Veto Function in Vitro and in Vivo

Pages 175-191 | Published online: 10 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Hans-Georg Rammensee, Olaf Rötzschke & Kirsten Falk. (1993) Self Tolerance of Natural MHC Class I Ligands. International Reviews of Immunology 10:4, pages 291-300.
Read now

Articles from other publishers (27)

Mark L. Tykocinski. 2014. Micro- and Nanoengineering of the Cell Surface. Micro- and Nanoengineering of the Cell Surface 1 25 .
Mark L. Tykocinski. 2013. Fusion Protein Technologies for Biopharmaceuticals. Fusion Protein Technologies for Biopharmaceuticals 453 473 .
Marloes Waanders, Leo Van De Watering & Anneke Brand. 2010. Alternatives to Blood Transfusion in Transfusion Medicine. Alternatives to Blood Transfusion in Transfusion Medicine 47 59 .
MARLOES WAANDERS, LEO VAN DE WATERING & ANNEKE BRAND. (2008) Immunomodulation and allogeneic blood transfusion. Transfusion Alternatives in Transfusion Medicine 10:3, pages 127-138.
Crossref
Mark L. Tykocinski, Jui-Han Huang, Matthew C. Weber & Michal Dranitzki-Elhalel. 2008. National Institute of Allergy and Infectious Diseases, NIH. National Institute of Allergy and Infectious Diseases, NIH 349 356 .
Hugh I. McFarlandSusan A. HansalDiane I. MorrisDaniel W. McVicarPaul E. LoveAmy S. Rosenberg. (2003) Signaling through MHC in transgenic mice generates a population of memory phenotype cytolytic cells that lack TCR. Blood 101:11, pages 4520-4528.
Crossref
Pavel Chrobak & Ronald E. Gress. (2001) Veto Activity of Activated Bone Marrow Does Not Require Perforin and Fas Ligand. Cellular Immunology 208:2, pages 80-87.
Crossref
Bruce R. Blazar, Christopher J. Lees, Paul J. Martin, Randolph J. Noelle, Byoung Kwon, William Murphy & Patricia A. Taylor. (2000) Host T Cells Resist Graft-Versus-Host Disease Mediated by Donor Leukocyte Infusions. The Journal of Immunology 165:9, pages 4901-4909.
Crossref
Uwe D Staerz, Dong-Soon Lee & Yan Qi. (2000) Induction of specific immune tolerance with hybrid antibodies. Immunology Today 21:4, pages 172-176.
Crossref
Francesco L. Ierino, Kazuhiko Yamada, Tevis Hatch, James Rembert & David H. Sachs. (1999) Peripheral Tolerance to Class I Mismatched Renal Allografts in Miniature Swine: Donor Antigen-Activated Peripheral Blood Lymphocytes from Tolerant Swine Inhibit Antidonor CTL Reactivity. The Journal of Immunology 162:1, pages 550-559.
Crossref
Peter T. DanielArne KroidlJoachim KoppIsrid SturmGerhard MoldenhauerBernd DörkenAntonio Pezzutto. (1998) Immunotherapy of B-Cell Lymphoma With CD3x19 Bispecific Antibodies: Costimulation via CD28 Prevents “Veto” Apoptosis of Antibody-Targeted Cytotoxic T Cells. Blood 92:12, pages 4750-4757.
Crossref
Yan Qi & Uwe D. Staerz. (1998) Specific inhibition of CD4+ T lymphocytes by a hybrid antibody. Nature Biotechnology 16:3, pages 271-275.
Crossref
Zoltan A. Nagy. (1998) Immunological right of veto. Nature Biotechnology 16:3, pages 237-238.
Crossref
Peter T. Daniel, Arne Kroidl, Sophie Cayeux, Christian Scholz, Isrid Sturm, Thomas Blankenstein, Antonio Pezzutto & Bernd Dörken. 1998. Gene Therapy of Cancer. Gene Therapy of Cancer 265 276 .
Laurent GenestierRomain PaillotNathalie Bonnefoy-BerardGeneviéve MeffreMonique FlacherDavid FèvreYong Jun LiuPhilippe Le BouteillerHerman WaldmannVictor H. EngelhardJacques BanchereauJean Pierre Revillard. (1997) Fas-Independent Apoptosis of Activated T Cells Induced by Antibodies to the HLA Class I α1 Domain. Blood 90:9, pages 3629-3639.
Crossref
Jacky Woo, Marie-Christine Corjeno, Lan Gao, Joel D Taurog, Robert E Hammer & Roland Buelow. (1997) Monoclonal antibody to the HLA class I α3 domain inhibits T cell activation and prolongs cardiac allograft survival in HLA— transgenic mice. Transplant Immunology 5:2, pages 112-121.
Crossref
Barbara J. van der Mast & Aggie H.M.M. Balk. (1997) EFFECT OF HLA-DR-SHARED BLOOD TRANSFUSION ON THE CLINICAL OUTCOME OF HEART TRANSPLANTATION1. Transplantation 63:10, pages 1514-1519.
Crossref
Barbara J. van der Mast, Henk E. Vi??tor, Ellen M.W. van der Meer-Prins, Simone P.M.J. van Bree, Anneke Brand, Peter J. van den Elsen & Frans H.J. Claas. (1997) MODULATION OF THE T CELL COMPARTMENT BY BLOOD TRANSFUSION. Transplantation 63:8, pages 1145-1154.
Crossref
Laurent Genestier, Romain Paillot, Nathalie Bonnefoy‐Berard, Herman Waldmann & Jean‐Pierre Revillard. (2005) T cell sensitivity to HLA class I‐mediated apoptosis is dependent on interleukin‐2 and interleukin‐4. European Journal of Immunology 27:2, pages 495-499.
Crossref
Judith M. Thomas, Kathryn M. Verbanac, John P. Smith, F. Melinda Carver, Jane Kasten-Jolly, Ulrike M. Gross, Lorita M. Rebellato, Carl E. Haisch & Francis T. Thomas. 1994. Rejection and Tolerance. Rejection and Tolerance 291 323 .
J. F. A. P. Miller. (1993) Self-nonself discrimination and tolerance in T and B lymphocytes. Immunologic Research 12:2, pages 115-130.
Crossref
Gert Riethmuuller, Ernst Peter Rieber, Stefan Kiefersauer, Jourg Prinz, Petervander Lubbe, Bruno Meiser, Ferdy Breedveld, Josef Eisenburg, Klaus Kruuger, Kai Deusch, Martin Sanders & Christian Reiter. (2006) From Antilymphocyte Serum to Therapeutic Monoclonal Antibodies: First Experiences with a Chimeric CD4 Antibody in the Treatment of Autoimmune Disease. Immunological Reviews 129:1, pages 81-104.
Crossref
Jacques F.A.P. Miller & Grant Morahan. 1992. Molecular Immunology. Molecular Immunology 79 97 .
Judith M. Thomas, Kathryn M. Verbanac & Francis T. Thomas. (1991) The veto mechanism in transplant tolerance. Transplantation Reviews 5:4, pages 209-229.
Crossref
Kathryn J. Wood. (1991) Transplantation tolerance. Current Opinion in Immunology 3:5, pages 710-714.
Crossref
Suryaprakash R. SambharaRichard G. Miller. (1991) Programmed Cell Death of T Cells Signaled by the T Cell Receptor and the α 3 Domain of Class I MH . Science 252:5011, pages 1424-1427.
Crossref
Hans‐Georg Rammensee & Daniela Hügin. (2005) Masking of veto function in vivo by activated CD4 + T lymphocytes . European Journal of Immunology 19:4, pages 643-648.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.